Table 4 The validity of DW-ADC, DT-FA, and DT-MD in differentiation of normal, benign, and malignant endometrium
AUC (95% CI) | P value | Cutoff point | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | Accuracy (%) | |
|---|---|---|---|---|---|---|---|---|
Differentiating benign and malignant endometrial lesions | ||||||||
DW-ADC | 1.0 (1.0–1.0) | < 0.001* | 1.21 | 89.5 | 95.5 | 94.4 | 91.3 | 92.7 |
DT-FA | 0.47 (0.29–0.65) | 0.09 | 0.294 | 55.0 | 52.4 | 52.4 | 55.0 | 53.7 |
DT-MD | 1.0 (1.0–1.0) | < 0.001* | 1.03 | 95.0 | 100.0 | 100.0 | 95.5 | 97.6 |
Differentiating normal and benign endometrial lesions | ||||||||
DW-ADC | 1.0 (1.0–1.0) | 0.006* | 1.495 | 61.9 | 58.3 | 56.5 | 63.6 | 60.0 |
DT-FA | 0.70 (0.55–0.85) | 0.02* | 0.342 | 76.2 | 52.0 | 53.3 | 68.8 | 58.7 |
DT-MD | 1.0 (1.0–1.0) | < 0.001* | 1.5065 | 100.0 | 96.0 | 95.5 | 100.0 | 97.8 |
Differentiating normal and malignant endometrial lesions | ||||||||
DW-ADC | 1.0 (1.0–1.0) | < 0.001* | 1.190 | 95.0 | 91.7 | 90.5 | 95.0 | 93.2 |
DT-FA | 0.69 (0.54–0.85) | 0.02* | 0.3415 | 75.0 | 52.0 | 52.0 | 72.0 | 62.2 |
DT-MD | 1.0 (1.0–1.0) | < 0.001* | 1.032 | 95.0 | 100.0 | 100.0 | 95.5 | 97.6 |